Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients
Clinical trial NCT02401737 · COMPLETED
Trial details
- NCT number
- NCT02401737
- Sponsor
- Novira Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-31
- Primary completion
- 2016-05-18
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.